FK 973

Known as: FK-973, FK973 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2003
012319882003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
The enantiospecific synthesis of FK973, and thus a formal enantiospecific synthesis of the antitumor antibiotic (+)-FR900482, is… (More)
Is this relevant?
2003
2003
FR900482 (1) and FR66979 (2) are structurally novel natural products isolated by Fujisawa in 1987 and have been shown to be… (More)
Is this relevant?
1998
1998
Purpose: FK973, a substituted dihydrobenzoxazine, is an antitumor antibiotic which has shown high therapeutic efficacy in a phase… (More)
  • table 1
  • table 2
  • figure 3
  • figure 2
  • figure 5
Is this relevant?
1994
1994
The genotoxic activity of a new antitumor agent, FK973, was compared with that of mitomycin C (MMC) in eukaryotic and prokaryotic… (More)
Is this relevant?
1991
1991
FK973 is a novel, substituted dihydrobenzoxazine structurally similar to mitomycin. FK973 lacks cross-resistance with mitomycin… (More)
  • figure 1
  • table 2
  • table 1
Is this relevant?
1991
1991
A novel antitumor antibiotic, 11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1, 11-diazatetracyclo [7.4.1.0(2,7).0(10,12… (More)
Is this relevant?
1991
1991
FK973 (11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1, 11-diazatetracyclo [7.4.1.0.0] tetradeca-2, 4, 6-trien-6, 9-diyl… (More)
Is this relevant?
1989
1989
Our previous study showed that FK973 (11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1,11- diazatetracyclo[7.4.1.0(2,7)0(10,12… (More)
Is this relevant?
1988
1988
Seven small- (SCLC) and four non-small-cell (NSCLC) lung cancer cell lines were used to examine the in vitro cytotoxicity of… (More)
  • table 1
  • figure 2
  • table 2
  • table 3
  • figure 3
Is this relevant?
1988
1988
FK973, a new, substituted dihydrobenzoxazine (11-acetyl-8-carbamoyloxymethyl-4-formyl-14-oxa-1,11- diazatetracyclo[7.4.1.0.0… (More)
  • figure 1
  • table 2
  • table 3
  • table 4
  • figure 2
Is this relevant?